GCP
WVE icon

GSA Capital Partners’s Wave Life Sciences WVE Stock Holding History

GSA Capital Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.05M Buy
+282,719
New +$3.68M 0.13% 160
2025
Q4 		– Sell
-51,198
Closed -$375K – 2144
2025
Q3 		$375K Buy
+51,198
New +$414K 0.03% 1059
2025
Q2 		– Sell
-12,643
Closed -$102K – 2203
2025
Q1 		$102K Buy
+12,643
New +$138K 0.01% 1494
2024
Q4 		– Sell
-63,513
Closed -$521K – 2077
2024
Q3 		$521K Buy
63,513
+8,255
+15% +$49.3K 0.04% 870
2024
Q2 		$276K Sell
55,258
-39,779
-42% -$227K 0.02% 1314
2024
Q1 		$586K Buy
+95,037
New +$476K 0.05% 789
2023
Q3 		– Sell
-83,210
Closed -$303K – 1964
2023
Q2 		$303K Buy
+83,210
New +$336K 0.03% 1045
2022
Q2 		– Sell
-196,887
Closed -$394K – 1853
2022
Q1 		$394K Buy
196,887
+23,242
+13% +$56.9K 0.05% 711
2021
Q4 		$545K Buy
173,645
+140,876
+430% +$585K 0.07% 537
2021
Q3 		$161K Buy
+32,769
New +$199K 0.02% 1276
2018
Q4 		– Sell
-7,600
Closed -$380K – 1787
2018
Q3 		$380K Sell
7,600
-1,900
-20% -$85.7K 0.02% 1211
2018
Q2 		$363K Sell
9,500
-10,600
-53% -$456K 0.02% 1306
2018
Q1 		$806K Buy
20,100
+9,200
+84% +$387K 0.04% 797
2017
Q4 		$383K Buy
+10,900
New +$318K 0.02% 1083

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

GSA Capital Partners's WVE Position: Q1 2026 in Review

GSA Capital Partners opened a new position in Wave Life Sciences (WVE) in Q1 2026: 282,719 shares worth $2.05M. The stake represents 0.13% of the portfolio and ranks #160 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in WVE as recently as Q3 2025.

GSA Capital Partners first reported a position in WVE in Q4 2017 and has held it in 14 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • GSA Capital Partners held 282,719 shares of Wave Life Sciences worth $2.05M as of Q1 2026.
  • Wave Life Sciences was a new GSA Capital Partners position in Q1 2026.
  • Wave Life Sciences made up 0.13% of GSA Capital Partners's portfolio in Q1 2026, its #160 holding.
  • GSA Capital Partners first reported a position in Wave Life Sciences in Q4 2017 and has held it in 14 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.